Autophagy in ischemic heart disease
- PMID: 19179668
- PMCID: PMC2765251
- DOI: 10.1161/CIRCRESAHA.108.187427
Autophagy in ischemic heart disease
Abstract
Autophagy is a major catabolic pathway by which mammalian cells degrade and recycle macromolecules and organelles. It plays a critical role in removing protein aggregates, as well as damaged or excess organelles, to maintain intracellular homeostasis and to keep the cell healthy. In the heart, autophagy occurs at low levels under normal conditions, and defects in this process cause cardiac dysfunction and heart failure. However, this pathway is rapidly upregulated under environmental stress conditions, including ATP depletion, reactive oxygen species, and mitochondrial permeability transition pore opening. Although autophagy is enhanced in various pathophysiological conditions, such as during ischemia and reperfusion, the functional role of increased autophagy is not clear and is currently under intense investigation. In this review, we discuss the evidence for autophagy in the heart in response to ischemia and reperfusion, identify factors that regulate autophagy, and analyze the potential roles autophagy might play in cardiac cells.
Figures
Similar articles
-
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H333-41. doi: 10.1152/ajpheart.01012.2008. Epub 2008 Dec 5. Am J Physiol Heart Circ Physiol. 2009. PMID: 19060123 Free PMC article.
-
Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.PLoS One. 2015 Mar 10;10(3):e0118834. doi: 10.1371/journal.pone.0118834. eCollection 2015. PLoS One. 2015. PMID: 25756500 Free PMC article.
-
Recycle or die: the role of autophagy in cardioprotection.J Mol Cell Cardiol. 2008 Apr;44(4):654-61. doi: 10.1016/j.yjmcc.2008.01.010. Epub 2008 Feb 13. J Mol Cell Cardiol. 2008. PMID: 18353358 Free PMC article. Review.
-
Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.Planta Med. 2011 Jul;77(10):984-91. doi: 10.1055/s-0030-1250718. Epub 2011 Jan 31. Planta Med. 2011. PMID: 21283956
-
Abnormal mitochondrial function during ischemia reperfusion provides targets for pharmacological therapy.Methodist Debakey Cardiovasc J. 2009;5(3):2-7. doi: 10.14797/mdcj-5-3-2. Methodist Debakey Cardiovasc J. 2009. PMID: 20308957 Review.
Cited by
-
Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure.J Am Heart Assoc. 2016 Jul 29;5(8):e003551. doi: 10.1161/JAHA.116.003551. J Am Heart Assoc. 2016. PMID: 27473036 Free PMC article.
-
Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.Circ Res. 2010 Feb 19;106(3):463-78. doi: 10.1161/CIRCRESAHA.109.208801. Circ Res. 2010. PMID: 20167943 Free PMC article. Review.
-
Targeting lysosomes in human disease: from basic research to clinical applications.Signal Transduct Target Ther. 2021 Nov 8;6(1):379. doi: 10.1038/s41392-021-00778-y. Signal Transduct Target Ther. 2021. PMID: 34744168 Free PMC article. Review.
-
Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning.J Cereb Blood Flow Metab. 2011 Apr;31(4):1003-19. doi: 10.1038/jcbfm.2010.229. Epub 2011 Jan 12. J Cereb Blood Flow Metab. 2011. PMID: 21224864 Free PMC article. Review.
-
CD38 Causes Autophagic Flux Inhibition and Cardiac Dysfunction Through a Transcriptional Inhibition Pathway Under Hypoxia/Ischemia Conditions.Front Cell Dev Biol. 2020 Apr 17;8:191. doi: 10.3389/fcell.2020.00191. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32363189 Free PMC article.
References
-
- Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M, Mizushima N, Otsu K. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13:619–624. - PubMed
-
- Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature. 2000;406:902–906. - PubMed
-
- Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, Sue CM, Yamamoto A, Murakami N, Shanske S, Byrne E, Bonilla E, Nonaka I, DiMauro S, Hirano M. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) Nature. 2000;406:906–910. - PubMed
-
- Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev.Cell. 2004;6:463–477. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL060590/HL/NHLBI NIH HHS/United States
- R01 HL087023/HL/NHLBI NIH HHS/United States
- R01 AG021568-06/AG/NIA NIH HHS/United States
- R01 HL071091-04/HL/NHLBI NIH HHS/United States
- R01 HL071091/HL/NHLBI NIH HHS/United States
- R01 HL060590/HL/NHLBI NIH HHS/United States
- HL085577/HL/NHLBI NIH HHS/United States
- HL071091/HL/NHLBI NIH HHS/United States
- HL087023/HL/NHLBI NIH HHS/United States
- P01 HL085577-040004/HL/NHLBI NIH HHS/United States
- R01 HL087023-02/HL/NHLBI NIH HHS/United States
- P01 HL085577/HL/NHLBI NIH HHS/United States
- AG025168/AG/NIA NIH HHS/United States
- R01 AG021568/AG/NIA NIH HHS/United States
- R01 HL060590-11/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
